ANA Therapeutics Announces U.S. FDA Clearance Of IND Application To
Initiate Clinical Trial Of Niclosamide In COVID-19 Patients
/PRNewswire/ -- ANA Therapeutics (ANA), a Silicon Valley-based biotech
start-up announced today that the U.S. Food and Drug Administration (FDA)
has cleared...
